Focal therapy for intermediate risk prostate cancer registry
Part of Cancer, Kidney & urinary clinical trials.
This is a registry study for men with intermediate-risk prostate cancer who are getting a type of focal treatment (treating only the cancer spot, not the whole prostate). It collects data on treatments like HIFU, cryotherapy, and others to better understand their long-term results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have intermediate-risk prostate cancer, based on standard risk groups.
- You are expected to live more than 10 years.
- You had a targeted and systematic biopsy guided by MRI fusion before focal treatment.
- Your cancer (Gleason score 3+4 or 4+3) was found in an area seen on MRI, and that area was treated with a focal method like HIFU, cryotherapy, brachytherapy, or others.
- You have not had prior prostate cancer treatment other than active surveillance.
- You do not have high-risk, locally advanced, or metastatic prostate cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry tracks men with early-stage prostate cancer who choose focal therapy—a targeted treatment that destroys only the cancer area while preserving healthy prostate tissue. The study helps doctors understand how well this approach works and its safety.
This study is a registry for people who have already had focal therapy (targeted treatment) for prostate cancer at Queen Mary Hospital. It aims to collect information about these treatments, which may help improve future care.
This trial tests a gentler treatment called focal therapy that targets only the part of the prostate with cancer. It's for men whose prostate cancer has a Gleason score of 7, low PSA, and hasn't spread outside the prostate.
This study is tracking men who choose focal therapy (a targeted treatment) for their localized prostate cancer. It aims to learn how well this treatment works and how it affects quality of life.
This trial tests whether freezing only the cancer area in the prostate (focal cryotherapy) can control intermediate-risk prostate cancer. It aims to limit treatment to one tumor focus while closely checking results with targeted and follow-up testing.
This study looks at outcomes after “focal therapy,” a type of treatment that targets only part of the prostate, for people with newly diagnosed or returning prostate cancer. It may help researchers understand how well this targeted approach works and for whom.
Hear when a new Prostate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.